Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
A study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis
GermanyA study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa
BulgariaEvaluating the effect of semaglutide on wound healing in patients with diabetic foot ulcers
The NetherlandsA study to evaluate the efficacy and safety of lesigercept in adults with chronic spontaneous urticaria who do not have enough relief from antihistamines
BulgariaA study to evaluate the effectiveness of NAV-240 in adults with moderate-to-severe hidradenitis suppurativa
BulgariaStudy to evaluate the efficacy and safety of deucrictibant for the prevention and treatment of angioedema attacks in adults with acquired angioedema
AustriaA long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome
GermanyUsing 68Ga-FAPI-46 imaging to detect fibrosis in patients with inflammatory diseases such as Crohn's disease, ulcerative colitis, systemic sclerosis, and lung fibrosis.
The NetherlandsA safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
BelgiumStudy of the effect of hyperbaric oxygen therapy on the bacteria in chronic wounds
AustriaA study of donidalorsen for children with hereditary angioedema
ItalyA study to evaluate the long-term safety of apremilast in children with oral ulcers from Behçet’s disease or juvenile psoriatic arthritis
GreeceThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
